Access cutting-edge lung cancer treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
In this study, patients with small cell or non-small cell lung cancer will receive ADI-PEG 20, gemcitabine, and docetaxel after demonstrated progression on frontline therapy. In phase I of the study, up to 6 dose levels will be tested to find the recommended phase II dose (RP2D), after which patients enrolling to phase II will be treated at that dose level to assess efficacy. Although safety and tolerability has been previously determined in the sarcoma population, dose de-escalations of the che
Sponsor: Washington University School of Medicine
Check if you qualify for this lung cancer clinical trial in St Louis, MO
If you're searching for lung cancer treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.